| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
REGENXBIO Inc (NASDAQ: RGNX)
RGNX Technical Analysis
5
| As on 9th Jun 2023 RGNX STOCK Price closed @ 20.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 26.96 & Strong Sell for SHORT-TERM with Stoploss of 28.09 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RGNXSTOCK Price
| Open | 20.26 | Change | Price | % |
| High | 20.46 | 1 Day | -0.14 | -0.69 |
| Low | 19.80 | 1 Week | 2.60 | 14.86 |
| Close | 20.10 | 1 Month | 1.70 | 9.24 |
| Volume | 274100 | 1 Year | -12.90 | -39.09 |
| 52 Week High 35.04 | 52 Week Low 17.23 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RGNX Daily Charts |
RGNX Intraday Charts |
Whats New @ Bazaartrend |
RGNX Free Analysis |
|
|
RGNX Important Levels Intraday
| RESISTANCE | 21.37 |
| RESISTANCE | 20.96 |
| RESISTANCE | 20.71 |
| RESISTANCE | 20.46 |
| SUPPORT | 19.74 |
| SUPPORT | 19.49 |
| SUPPORT | 19.24 |
| SUPPORT | 18.83 |
RGNX Forecast May 2024
| 4th UP Forecast | 31.87 |
| 3rd UP Forecast | 28.1 |
| 2nd UP Forecast | 25.76 |
| 1st UP Forecast | 23.43 |
| 1st DOWN Forecast | 16.77 |
| 2nd DOWN Forecast | 14.44 |
| 3rd DOWN Forecast | 12.1 |
| 4th DOWN Forecast | 8.33 |
RGNX Weekly Forecast
| 4th UP Forecast | 29.33 |
| 3rd UP Forecast | 26.37 |
| 2nd UP Forecast | 24.54 |
| 1st UP Forecast | 22.71 |
| 1st DOWN Forecast | 17.49 |
| 2nd DOWN Forecast | 15.66 |
| 3rd DOWN Forecast | 13.83 |
| 4th DOWN Forecast | 10.87 |
RGNX Forecast2024
| 4th UP Forecast | 57.35 |
| 3rd UP Forecast | 45.4 |
| 2nd UP Forecast | 38.02 |
| 1st UP Forecast | 30.63 |
| 1st DOWN Forecast | 9.57 |
| 2nd DOWN Forecast | 2.18 |
| 3rd DOWN Forecast | -5.2 |
| 4th DOWN Forecast | -17.15 |
REGENXBIO Inc ( NASDAQ USA Symbol : RGNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RGNX Business Profile
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II; RGX-111, which is in Phase I clinical trial for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease; and RGX-501, which is in Phase I/II clinical trials to treat homozygous familial hypercholesterolemia. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop vectorized antibodies for the treatment of neurodegenerative diseases. The company was formerly known as ReGenX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland. Address: 9600 Blackwell Road, Rockville, MD, United States, 20850
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service